| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |